Dupilumab combined with a short-term narrowband-ultraviolet B phototherapy in a pediatric case of severe atopic dermatitis

dc.contributor.authorKavak, Ayse
dc.contributor.authorAydogmus, Cigdem
dc.contributor.authorYilmaz, Kubra
dc.date.accessioned2023-02-21T12:32:56Z
dc.date.available2023-02-21T12:32:56Z
dc.date.issued2022-01-01
dc.description.abstractRecently, dupilumab treatment in atopic dermatitis (AD) has been an effective and safe option in terms of adverse effects. However, combination therapies can sometimes be better at increasing efficacy or reducing adverse effects or cumulative doses. Early combination therapies may be more rational, especially considering that dupilumab treatment alone is less effective and has a late-onset efficacy. Here, we discussed dupilumab and a short-term narrowband ultraviolet B combination therapy in a child with AD.
dc.description.issue1
dc.description.pages39-41
dc.description.volume56
dc.identifier.doi10.4274/turkderm.galenos.2021.67424
dc.identifier.urihttps://hdl.handle.net/11443/1324
dc.identifier.urihttp://dx.doi.org/10.4274/turkderm.galenos.2021.67424
dc.identifier.wosWOS:000774142400007
dc.publisherDERI ZUHREVI HASTALIKLAR DERNEGI
dc.relation.ispartofTURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
dc.subjectAtopic dermatitis
dc.subjectdupilumab
dc.subjectnarrowband UVB
dc.titleDupilumab combined with a short-term narrowband-ultraviolet B phototherapy in a pediatric case of severe atopic dermatitis
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dupilumab combined with a short-term narrowband-ultraviolet B phototherapy in a pediatric case of.pdf
Size:
630.33 KB
Format:
Adobe Portable Document Format

Collections